-
Metabolic dependency of malonate protection against cardiac ischemia–reperfusion injury
Wang, Q., Hu, X., Xiao, Y., Nederlof, R., Nikolaou, P.-E., Chania, C., Bakker, D., Singh, A. K., Hollmann, M. W., Weber, N. C., Schomakers, B., van Weeghel, M. & Zuurbier, C. J., 2026, (E-pub ahead of print) In: Basic Res. Cardiol..Research output: Contribution to Journal › Article › Academic › peer-review
-
Is boosting OXPHOS/FAO gene pathways the final end-mechanism of SGLT2i protection?
Hu, X. & Zuurbier, C. J., Jun 2025, In: Journal of Molecular and Cellular Cardiology Plus. 12, p. 100297Research output: Contribution to Journal › Article › Academic › peer-review
-
Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2
Chen, S., Wang, Q., Bakker, D., Hu, X., Zhang, L., van der Made, I., Tebbens, A. M., Kovácsházi, C., Giricz, Z., Brenner, G. B. B., Ferdinandy, P., Schaart, G., Gemmink, A., Hesselink, M. K. C., Rivaud, M. R., Pieper, M. P., Hollmann, M. W., Weber, N. C., Balligand, J.-L. & Creemers, E. E. & 2 others, , Oct 2024, In: Basic Research in Cardiology. 119, 5, p. 751-772 22 p.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
